Introducing a fashion line inspired by the two million Canadians affected by osteoporosis TORONTO, Feb. 6, 2019  – Models clad in stylish bubble wrap strutted down the Toronto Fashion Week® x […]

WILLS AND ESTATES Help Canadians Affected by Osteoporosis by Leaving a Gift in Your Will When you leave a gift to Osteoporosis Canada in your Will, you can feel confident […]

In 2008 the results of a small study were published reporting on the use of choline stabilized orthosilicic acid a form of silicon, or placebo in 184 women with low […]

No one likes to think about emergency planning but 57% of Canadian adults don’t have a will, and that number goes up to 89% among millennials. Having a solid estate […]

Osteoporosis Canada advises individuals on denosumab therapy to discuss their treatment with their physician prior to delaying therapy, stopping therapy or missing a scheduled dose.   Denosumab (Prolia) has been […]

Denosumab (Prolia) has been shown to reduce the risk of fracture in postmenopausal women and men ≥50 years old with osteoporosis. It has also been approved for steroid induced bone […]

A recent study, Annual High-Dose Oral Vitamin D and Falls and Fractures in Older Women, published in the Journal of the American Medical Association (JAMA), showed that a single large […]

Dr. Adrian Lau, Dr. Rowena Ridout, Dr. Claudia Gagnon, Dr. Zahra Bardai, Dr. Emma Billington and Dr. Wendy Ward. Recommendations from Osteoporosis Canada Rapid Response Team. LeBoff and colleagues (1) […]

St. Michael’s Hospital celebrates the 20th anniversary of the establishment of FLS St. Michael’s Hospital celebrates the 20th anniversary of the establishment of FLS St. Michael’s Hospital (SMH) in Toronto […]